Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

T-0901317 induces severe lipogenesis in diabetic mice

Jan. 30, 2004

Niaspan completes European mutual recognition procedure

Jan. 29, 2004

Improved pregnancy rates found with Menopur in women undergoing IVF

Jan. 29, 2004

New antidiabetic glycogen phosphorylase inhibitors under study at Aventis

Jan. 29, 2004

Selective or dual GSK-3/PKC inhibitors prepared and tested at Janssen

Jan. 29, 2004

Lipid profile changes found with pioglitazone and metformin in obese patients with type 2 diabetes

Jan. 29, 2004

Novel glucocorticoid receptor modulators designed at Boehringer Ingelheim

Jan. 29, 2004

Use of beta-blockers reduces fracture risk

Jan. 29, 2004

Wyeth files IND for compound originating from ArQule collaboration

Jan. 28, 2004

Novel histamine H3 receptor ligands discovered by Novo Nordisk team

Jan. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...